ANI Pharmaceuticals Inc
SWB:BSFA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ANI Pharmaceuticals Inc
SWB:BSFA
|
US |
|
Dexus
F:0DPS
|
AU |
Intrinsic Value
The intrinsic value of 
ANI Pharmaceuticals Inc (BSFA) under the Base Case is 115.58 EUR per share.
Compared with the current market price of 71.5 EUR, the stock appears
Undervalued by 38% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What ANI Pharmaceuticals Does
ANI Pharmaceuticals makes and sells prescription medicines in the United States. Its business includes branded drugs, generic drugs, and a growing set of specialty and rare-disease treatments. It also manufactures some of its own products, which gives it more control over supply for medicines that can be hard to make reliably.
- Headquarters
- United States of America US
- Employees
- 970
- IPO date
- May 4, 2000
Revenue & Expenses Breakdown
ANI Pharmaceuticals Inc
Earnings Waterfall
ANI Pharmaceuticals Inc
The intrinsic value for ANI Pharmaceuticals Inc (BSFA) under the Base Case is 115.58 EUR.
Compared with the current market price of 71.5 EUR, the stock appears Undervalued by 38% .